A temperature range, a number of hours, and a standard name. None of the three mean what buyers assume. What ISTA 7D, 7E and Standard 20 actually certify, why you set the acceptance criteria, and what to ask before you qualify a shipper for a lane.
When your regulatory lead audits your contract manufacturer, the job is not to pass. It is to produce evidence fast enough that your timeline does not slip. What they should be able to hand over, how fast, and what real audit support looks like.
Volumetric absorptive microsampling fixes the volume half of the hematocrit problem, not the recovery half. What the published validation data shows, and how to choose between a card and a VAMS tip.
Patient centric sampling is a design requirement, not a device category. Here is what the term actually covers, the three questions that decide whether it fits your program, and when a collection kit is the wrong answer.
Professional use kits need account verification, organization level accounts, pricing behind a login and a real integration with the warehouse. What a clinic ordering portal has to get right.
Between a quote and a purchase order there is real engineering work. What a paid scoping engagement should deliver, how the credit should work, and the red flags that mean you are buying a sales pitch.
Most kit quotes come back slow because the request was incomplete. The component specs, program facts and regulatory answers a bill of materials has to carry before anyone can price it.
Validation confirms that a defined process is reproducible. It cannot create the definition. What development has to produce first, and how to tell you are validating too early.
What AQL actually means, how a sampling plan gets chosen, why claims of 100 percent final inspection usually do not hold up, and the six questions to ask a kit supplier.
Prepaid return labels carry a stated validity of about a year, but they start getting rejected far earlier. Why kit programs are hit hardest, and how to print and rotate labels so it does not happen.